Addus HomeCare (ADUS) Competitors $112.64 -5.36 (-4.54%) Closing price 03:59 PM EasternExtended Trading$112.74 +0.10 (+0.09%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADUS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and VCYTShould you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Addus HomeCare vs. Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent LifeStance Health Group Veracyte Addus HomeCare (NASDAQ:ADUS) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk. Is ADUS or GH more profitable? Addus HomeCare has a net margin of 6.50% compared to Guardant Health's net margin of -59.05%. Addus HomeCare's return on equity of 9.62% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Addus HomeCare6.50% 9.62% 7.37% Guardant Health -59.05%-19,157.20%-25.96% Do analysts rate ADUS or GH? Addus HomeCare currently has a consensus price target of $142.57, suggesting a potential upside of 20.82%. Guardant Health has a consensus price target of $53.29, suggesting a potential upside of 6.38%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Guardant Health 0 Sell rating(s) 0 Hold rating(s) 20 Buy rating(s) 1 Strong Buy rating(s) 3.05 Which has more volatility & risk, ADUS or GH? Addus HomeCare has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Does the MarketBeat Community prefer ADUS or GH? Addus HomeCare received 28 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.76% of users gave Guardant Health an outperform vote while only 69.09% of users gave Addus HomeCare an outperform vote. CompanyUnderperformOutperformAddus HomeCareOutperform Votes33369.09% Underperform Votes14930.91% Guardant HealthOutperform Votes30571.76% Underperform Votes12028.24% Does the media prefer ADUS or GH? In the previous week, Guardant Health had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 19 mentions for Guardant Health and 7 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.13 beat Guardant Health's score of 0.57 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 8 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in ADUS or GH? 95.3% of Addus HomeCare shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 4.6% of Addus HomeCare shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, ADUS or GH? Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAddus HomeCare$1.21B1.79$62.52M$4.4326.64Guardant Health$774.00M8.02-$479.45M-$3.39-14.78 SummaryAddus HomeCare beats Guardant Health on 13 of the 19 factors compared between the two stocks. Get Addus HomeCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADUS vs. The Competition Export to ExcelMetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.13B$3.15B$5.60B$8.65BDividend YieldN/A0.36%5.27%4.19%P/E Ratio26.5229.9327.3320.13Price / Sales1.761.13412.21156.99Price / Cash21.6517.2938.2534.64Price / Book2.663.577.154.74Net Income$62.52M-$57.02M$3.23B$247.88M7 Day Performance3.54%-0.04%3.49%2.64%1 Month Performance4.56%0.66%12.92%9.95%1 Year Performance-1.74%28.34%32.15%15.33% Addus HomeCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADUSAddus HomeCare4.7903 of 5 stars$112.64-4.5%$142.57+26.6%+1.0%$2.07B$1.21B25.7833,200Positive NewsAnalyst ForecastAnalyst RevisionGHGuardant Health3.3316 of 5 stars$49.53+3.1%$53.29+7.6%+66.6%$6.14B$774.00M-13.911,790Insider TradeOPCHOption Care Health4.1511 of 5 stars$31.67-0.7%$35.50+12.1%+11.9%$5.19B$5.19B26.615,600Positive NewsRDNTRadNet3.5177 of 5 stars$59.07+0.7%$69.75+18.1%-3.6%$4.43B$1.87B-843.748,970Positive NewsBTSGBrightSpring Health Services0.6942 of 5 stars$23.86-1.0%$23.56-1.3%+98.4%$4.16B$11.86B-91.7735,000News CoveragePositive NewsSHCSotera Health2.568 of 5 stars$12.36+0.5%$15.80+27.8%+3.0%$3.51B$1.11B49.443,000Positive NewsHigh Trading VolumeSGRYSurgery Partners2.7324 of 5 stars$23.36+0.7%$33.56+43.6%-9.2%$2.99B$3.17B-48.6712,200Positive NewsPRVAPrivia Health Group3.4174 of 5 stars$23.24+0.2%$27.77+19.5%+35.7%$2.83B$1.80B232.42810CONConcentra Group Holdings ParentN/A$22.09+0.3%$28.50+29.0%N/A$2.81B$1.93B16.4911,000Positive NewsLFSTLifeStance Health Group2.0836 of 5 stars$5.88+0.7%$8.50+44.6%+6.9%$2.29B$1.28B-22.626,640VCYTVeracyte4.2141 of 5 stars$27.85+1.4%$40.90+46.9%+33.5%$2.18B$463.39M-185.67790 Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives LifeStance Health Group Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADUS) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.